Clinical significance of prostate 18F-labelled fluorodeoxyglucose uptake on positron emission tomography/computed tomography: A five-year review

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 9

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Radiology

ISSN

1949-8470

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Radiol. Sep 28, 2017; 9(9): 350-358
Published online Sep 28, 2017. doi: 10.4329/wjr.v9.i9.350

Full Size Figure Download Figure

Figure 5 Flowchart showing clinical outcomes in patients with elevated prostatic ¹⁸F-labelled fluorodeoxyglucose uptake.

Citation: Chetan MR, Barrett T, Gallagher FA. Clinical significance of prostate ¹⁸F-labelled fluorodeoxyglucose uptake on positron emission tomography/computed tomography: A five-year review. World J Radiol 2017; 9(9): 350-358
URL: https://www.wjgnet.com/1949-8470/full/v9/i9/350.htm
DOI: https://dx.doi.org/10.4329/wjr.v9.i9.350

Chetan MR, Barrett T, Gallagher FA. Clinical significance of prostate ¹⁸F-labelled fluorodeoxyglucose uptake on positron emission tomography/computed tomography: A five-year review. World J Radiol 2017; 9(9): 350-358 [PMID: 29098068 DOI: 10.4329/wjr.v9.i9.350]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.